There are difficult issues confronting physicians generally, regardless of whether they are primary care physicians or specialists or employed or in private practice. The list is long and growing as more and more requirements, costs, mandates, and regulations are being inflicted in an environment of decreasing compensation. All of these lend to the rapidly lost freedom and autonomy for a medical profession where these are foundational. It seems clear that the issues addressed are related to the system and not the essence of the profession’s mission, providing health care to those in need in a trusting relationship between patients and…
Author: Rutali Thakur
In a Healio video exclusive, Sam Jactel, CEO and founder of Ayble Health, highlights how the symptom management mobile app could improve quality of life for patients with chronic gastrointestinal conditions. Jactel, himself an ulcerative colitis patient, said he created the app after he had a “rocky” experience with his own treatment. He had relapsed in disease remission five times in the past 9 years, despite adherence to prescription medications and being seen by multiple GI providers. He wanted to try diet and psychology to supplement his therapy, but he had no resources within his reach.
No matter the size, running a practice is a challenge. By being aware of — and more importantly steering clear of — some common but unrecognized pitfalls, you can increase your odds for success and profitability. A physician who in the past has led medical groups as both chief medical officer and president, Gerda Maissel, MD, president of My MD Advisor, a private patient advocacy group, has seen the good, bad, and ugly of practice administration. There’s a spectrum of infractions: anything from doctors making inappropriate jokes with staff or patients, to failing to establish key relationships with other critical…
Dr. Fred Rosenberg interviews Harold Miller, president and CEO of the Center for Healthcare Quality and Payment Reform, national policy center that works to improve healthcare payment and delivery systems. Mr. Miller discusses how our current health care model encourages consolidation and the challenges this creates for private practice physicians. Join Dr. Rosenberg and Mr. Miller as they explore different types of healthcare payment models, including a Patient-Centered Payment System, which would allow for patients to receive the services that will best address their specific health problems, and for physicians to receive adequate resources to support the cost of delivering services in…
MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–Boomerang Medical, a women-led bioelectronic medicine company, has announced the enrollment of the first patients in its U.S. clinical trial evaluating the use of nerve stimulation as a potential treatment for Crohn’s disease and ulcerative colitis, the two most common forms of Inflammatory Bowel Disease (IBD). This study marks a significant milestone for the company, which was granted Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) earlier this year for its bioelectronic technology targeting the treatment of IBD.
Merck said on Sunday it will buy Prometheus Biosciences for about $10.8 billion, picking up a promising experimental treatment for ulcerative colitis and Crohn’s disease and building up its presence in immunology. Merck will pay $200 per share for the California-based biotechnology company that specializes in treatments for autoimmune diseases, representing a 75.4% premium to Prometheus’ last closing price. Shares of Prometheus were trading at $194.49 before the bell on Monday. “This is allowing us to move into immunology in a strong way and will allow us sustainable growth, we think, well into the 2030s given the long patent life,” Merck Chief Executive…
Two of the most important goals in the treatment of patients with inflammatory bowel disease are to improve patient quality of life and increases the odds of remission. Patients with IBD want to be able to travel without limitations, predict flares without invasive testing, and manage symptoms without being restricted to immune-suppressing options. Fortunately, new resources and advancements including IBD Passport, a website with information for travelers with IBD, wearable technology to monitor symptoms, and an increased emphasis on dietitian’s role in multidisciplinary care are making patient desires even more attainable.
IRVINE, Calif., April 17, 2023 (GLOBE NEWSWIRE) — Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical diagnostic products, is pleased to announce that inFoods® IBS, a revolutionary new approach to alleviate Irritable Bowel Syndrome (IBS) symptoms, is now available at the flagship office of Gastro Health in Miami, with plans expand into the other Gastro Health offices in the future.
HIMSS 2023 kicked off Monday in Chicago. Follow our live blog for the latest updates and happenings from the conference. Epic Systems is working with Microsoft to integrate generative AI technology into its electronic health record software for the first time, the companies said Monday. The announcement was made in conjunction with the first day of the HIMSS conference, which is being held in Chicago this week.
The US Food and Drug Administration (FDA) has granted Fast Track designation for Agenus’ combination therapy for the treatment of colorectal cancer. The FDA awarded the Fast Track status for the investigation of a botensilimab (AGEN1181) and balstilimab (AGEN2034) combination. The combination therapy has been approved to treat non-microsatellite instability-high (non-MSI-H)/deficient mismatch repair metastatic colorectal cancer patients, with no signs of active liver involvement.